Two EEG channels do not make a 'quantitative eeg (QEEG)': A response to widge, avery and zarkowski (2013)

Brain Stimulation

Volumn 7, Issue 1, 2014, Pages 146-148

  Arns, Martijn ^a,b   Olbrich, Sebastian ^c  

^a RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ELECTROENCEPHALOGRAM; ENDOPHENOTYPE; GENETIC POLYMORPHISM; HUMAN; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84891837118     PISSN: 1935861X     EISSN: 18764754     Source Type: Journal    
DOI: 10.1016/j.brs.2013.09.009     Document Type: Letter

References (17)

1. A.S. Widge, D.H. Avery, and P. Zarkowski Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation Brain Stimul 2013 [Epub ahead of print]. http://dx.doi.org/10.1016/j.brs.2013.05.001
2. S. Olbrich, and S.M. Arns EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response Int Rev Psychiatry 2013 [Epub ahead of print]. http://dx.doi.org/10.3109/09540261.2013.816269
3. G. Gratton, M.G. Coles, and E. Donchin A new method for off-line removal of ocular artifact Electroencephalogr Clin Neurophysiol 55 4 1983 468 484
4. B.W. McMenamin, A.J. Shackman, J.S. Maxwell, D.R. Bachhuber, A.M. Koppenhaver, and L.L. Greischar et al. Validation of ica-based myogenic artifact correction for scalp and source-localized EEG Neuroimage 49 3 2010 2416 2432
5. M. Arns, W.H.I.M. Drinkenburg, P.B. Fitzgerald, and J.L. Kenemans Neurophysiological predictors of non-response to rTMS in depression Brain Stimul 5 2012 569 576 10.1016/j.brs.2011.12.003
6. R.J. Barry, A.R. Clarke, S.J. Johnstone, C.A. Magee, and J.A. Rushby EEG differences between eyes-closed and eyes-open resting conditions Clin Neurophysiol 118 12 2007 2765 2773
7. H.F. Zoon, C.P. Veth, M. Arns, W.H. Drinkenburg, W. Talloen, and P.J. Peeters et al. EEG alpha power as an intermediate measure between brain-derived neurotrophic factor val66met and depression severity in patients with major depressive disorder J Clin Neurophysiol 30 3 2013 261 267
8. J.M. Gatt, S.A. Kuan, C. Dobson-Stone, R.H. Paul, R.T. Joffe, and A.H. Kemp et al. Association between BDNF val66met polymorphism and trait depression is mediated via resting EEG alpha band activity Biol Psychol 79 2 2008 275 284
9. G.E. Bruder, J.P. Sedoruk, J.W. Stewart, P.J. McGrath, F.M. Quitkin, and C.E. Tenke Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings Biol Psychiatry 63 12 2008 1171 1177
10. G.E. Bruder, J.W. Stewart, C.E. Tenke, P.J. McGrath, P. Leite, and N. Bhattacharya et al. Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant Biol Psychiatry 49 5 2001 416 425
11. C.E. Tenke, J. Kayser, C.G. Manna, S. Fekri, C.J. Kroppmann, and J.D. Schaller et al. Current source density measures of electroencephalographic alpha predict antidepressant treatment response Biol Psychiatry 70 4 2011 388 394
12. G. Ulrich, E. Renfordt, and K. Frick The topographical distribution of alpha-activity in the resting EEG of endogenous-depressive in-patients with and without clinical response to pharmacotherapy Pharmacopsychiatry 19 1986 272 273
13. J.A. Micoulaud-Franchi, R. Richieri, M. Cermolacce, A. Loundou, C. Lancon, and J. Vion-Dury Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study J Affect Disord 137 1-3 2012 156 160
14. M. Arns, D. Spronk, and P.B. Fitzgerald Potential differential effects of 9 Hz rTMS and 10 Hz rTMS in the treatment of depression Brain Stimul 3 2 2010 124 126
15. A. Conca, E. Swoboda, P. König, S. Koppi, W. Beraus, and A. Künz et al. Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment Hum Psychopharmacol 15 6 2000 429 438
16. M. Arns EEG-based personalized medicine in ADHD: individual alpha peak frequency as an endophenotype associated with nonresponse J Neurother 16 2 2012 123 141
17. R. Broughton, and J. Hasan Quantitative topographic electroencephalographic mapping during drowsiness and sleep onset J Clin Neurophysiol 12 4 1995 372 386